National Health Investors, Inc. (NYSE:NHI) Receives $83.86 Average Price Target from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have received an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $83.8571.

NHI has been the topic of a number of research reports. Wells Fargo & Company dropped their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Truist Financial lowered their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Cantor Fitzgerald reissued an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Finally, BMO Capital Markets lowered their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $80.04 on Monday. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The firm’s 50-day moving average price is $74.80 and its two-hundred day moving average price is $79.69. National Health Investors has a 52-week low of $67.94 and a 52-week high of $91.38. The stock has a market capitalization of $3.88 billion, a P/E ratio of 25.82, a P/E/G ratio of 3.64 and a beta of 0.51.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.6%. National Health Investors’s dividend payout ratio is 118.71%.

Insider Activity at National Health Investors

In other news, Director Robert A. Mccabe, Jr. purchased 890 shares of the company’s stock in a transaction on Monday, June 15th. The shares were bought at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. 2.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. International Assets Investment Management LLC acquired a new position in shares of National Health Investors during the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares during the period. Garton & Associates Financial Advisors LLC acquired a new stake in National Health Investors in the fourth quarter worth about $33,000. GAMMA Investing LLC grew its position in National Health Investors by 41.8% in the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 136 shares in the last quarter. Finally, Key Capital Management INC bought a new position in National Health Investors in the 4th quarter valued at about $47,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.